Pathway-enrichment analyses [13] of the SNPs that were included in the AD-PRS showed most significant genes to be related to amyloid-β and tau, but also to lipid metabolism and immunity, highlighting the role of microglia and its potential interaction with amyloid precursor protein (APP) metabolism in AD development. The gene discussed is MAPT; the disease is Alzheimer disease.